Medico Remedies Limited (NSE:MEDICO)
48.95
-0.06 (-0.12%)
Nov 25, 2025, 3:29 PM IST
Medico Remedies Revenue
Medico Remedies had revenue of 543.60M INR in the quarter ending September 30, 2025, with 38.15% growth. This brings the company's revenue in the last twelve months to 1.73B, up 22.55% year-over-year. In the fiscal year ending March 31, 2025, Medico Remedies had annual revenue of 1.51B with 4.15% growth.
Revenue (ttm)
1.73B
Revenue Growth
+22.55%
P/S Ratio
2.42
Revenue / Employee
8.06M
Employees
213
Market Cap
4.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% |
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% |
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% |
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% |
| Mar 31, 2021 | 1.22B | 337.54M | 38.08% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Biocon | 164.76B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Medico Remedies News
- 7 weeks ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn